J.B. Versluijs

No picture available
E-mail:
j.b.versluijs umcg.nl

Research

Publications
  1. Fracture Risk Reduction by Bisphosphonates in Mastocytosis?

    Onnes, M. C., van Doormaal, J. J., van der Veer, E., Versluijs, J. B., Arends, S. & Elberink, H. N. G. O., 2020, In : Journal of Allergy and Clinical Immunology: In Practice. 8, 10, p. 3557-3564 8 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  2. TLR3 agonists induce fibronectin aggregation by activated astrocytes: a role of pro-inflammatory cytokines and fibronectin splice variants

    Werkman, I., Sikkema, A. H., Versluijs, J. B., Qin, J., de Boer, P. & Baron, W., 17-Jan-2020, In : Scientific Reports. 10, 1, p. 532 16 p., 532.

    Research output: Contribution to journalArticleAcademicpeer-review

  3. Predictors of new fragility fractures after diagnosis of indolent systemic mastocytosis

    van der Veer, E., Arends, S., van der Hoek, S., Versluijs, J. B., de Monchy, J. G. R., Oude Elberink, H. N. G. & van Doormaal, J. J., Dec-2014, In : Journal of Allergy and Clinical Immunology. 134, 6, p. 1413-1421 9 p.

    Research output: Contribution to journalArticleAcademicpeer-review

View all (3) »

ID: 445333